DV
Dividend Vision

AUPH — Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (AUPH)

Total return is 397.4% over the past 25.1 years, 512.7 points behind SPY at 910.1%. Its deepest 1-year drawdown was 21.8%.

AUPH is a healthcare equity stock that trades as a single company security rather than a diversified fund. As a pharmaceutical company, it does not distribute regular dividends and carries no stated expense ratio typical of ETFs. This security appeals primarily to growth-oriented investors seeking exposure to the pharmaceutical sector rather than income-focused dividend investors.

AUPH key facts

Asset type
Stock
Asset class
Equity
Inception date
07/16/2001
Distribution frequency
None
Last close
$15.47
Market cap
$2,058,301,568
Average volume
826700.0
Beta
1.403
Payout ratio
0.0
P/E ratio
6.6681
Forward P/E
17.6367
EPS
$2.32